FDA approves new DNA-based test to determine blood compatibility
date:Oct 12, 2018
ods that involve the use of antisera, a blood serum that contains antibodies for testing. Serologic testing presents limitations and certain antisera may be scarce or unavailable.

A study was conducted to compare the typing results of the ID CORE XT Test with licensed serological reagents, the first FDA-approved molecular assay, and DNA sequencing tests. The results demonstrated comparable performance between the methods.

The approval of the ID CORE XT Test was granted to Progenika Biopharma S
4/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/11 03:34